Navigation Links
A new target for alcoholism treatment: Kappa opioid receptors
Date:5/22/2014

Philadelphia, PA, May 22, 2014 The list of brain receptor targets for opiates reads like a fraternity: Mu Delta Kappa. The mu opioid receptor is the primary target for morphine and endogenous opioids like endorphin, whereas the delta opioid receptor shows the highest affinity for endogenous enkephalins. The kappa opioid receptor (KOR) is very interesting, but the least understood of the opiate receptor family.

Until now, the mu opioid receptor received the most attention in alcoholism research. Naltrexone, a drug approved by the U.S. Food and Drug Administration for the treatment of alcoholism, acts by blocking opiate action at brain receptors and is most potent at the mu opioid receptor. In addition, research has suggested that a variant of the gene that codes for the mu opioid receptor (OPRM1) may be associated with the risk for alcoholism and the response to naltrexone treatment.

However, naltrexone also acts at the kappa opioid receptor and it has not been clear whether this effect of naltrexone is relevant to alcoholism treatment.

A growing body of research in animals implicates the KOR in alcoholism. Stimulation of the KOR, which occurs with alcohol intake, is thought to produce unpleasant and aversive effects. This receptor is hypothesized to play a role in alcohol dependence, at least in part, by promoting negative reinforcement processes. In other words, the theory postulates that during development of alcohol dependence, the KOR system becomes overstimulated, producing dysphoria and anhedonia, which then leads to further alcohol seeking and escalation of alcohol intake that serves to self-medicate those negative symptoms.

A new study in Biological Psychiatry, led by Dr. Brendan Walker at Washington State University, used a rat model of alcohol dependence to directly investigate the KOR system following chronic alcohol exposure and withdrawal.

They found that the KOR system is dysregulated in the amy
'/>"/>

Contact: Rhiannon Bugno
Biol.Psych@utsouthwestern.edu
214-648-0880
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Drug-target database lets researchers match old drugs to new uses
2. Genomic tumor testing to match lung cancer patients with targeted drugs transforms care
3. RELAX-AHF and PROTECT studies find targeting WHF may reduce readmissions and save lives
4. New treatment targeting versatile protein may protect brain cells in Parkinsons disease
5. Novel target found for chemotherapy-resistant leukemia cells
6. Scientists find way to target cells resistant to chemo
7. Gold nanoparticles help target, quantify breast cancer segments in a living cell
8. Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment
9. FDA approves first targeted drug for advanced stomach cancer
10. New pain relief targets discovered
11. CU researchers discover target for treating dengue fever
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... 22, 2015 Joan Lunden, award-winning American ... at the upcoming 32nd Annual Miami Breast Cancer ... Education Resource®, LLC (PER®) , shares that “a fast-growing, ... undetected if she had not followed up her clean ...
(Date:1/22/2015)... January 23, 2015 Recently, Weddingshe.com has added ... and has announced its highest annual revenues in the past ... its popular glamorous wedding dresses. , According to the sales ... wedding dress promotions for them in 2015. This point can ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... swiftly disarms the sentinels of the body's immune system, hampering ... agent, a new study shows. The results suggest medical treatment ... infection could counteract the toxin that anthrax produces in its ... to kill the bacteria themselves. , ...
... shows Hispanic children are more likely to suffer from ... of Arizona College of Medicine and the University of ... Children’s Assessment of Sleep Apnea study.,The study consisted of ... between ages 4 and 11. Parents were asked about ...
... were combining two new and experimental therapies -- using stem ... dystrophy. Their early work has shown some success in mice ... ,Writing in the journal Science, the team lead by Dr. ... and the University of Rome said certain stem cells //had ...
... time, food allergy -- especially to peanuts -- has been ... children. ,Asthma attacks are the most common reason for children ... Hospital in London and a team of experts. Despite great ... dropped. Roughly 50 children in the U.K. and more than ...
... no surprise that constant stress can make people sick, and ... study focused on 119 men and women who were taking ... was compared with that of 106 people of similar ages ... giving. Blood tests showed that a chemical called Interleukin-6 sharply ...
... Doppler ultrasound is better than unenhanced ultrasound at ... in the July issue of The Journal of ... of contrast enhanced and unenhanced endo-rectal ultrasound in ... all subjects, the imaging findings were compared with ...
Cached Medicine News:Health News:Stem cells offer hope for muscular dystrophy 2
(Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
(Date:1/22/2015)...  BiOptix is pleased to announce the appointment of Dr. ... and Biochemistry. Scott joins the company after previous scientific leadership ... the course of his nearly 20 year career in ... nationally recognized thought leader in the biosensor field and ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Reportlinker.com announces that a new market research report is ... Devices Market Outlook to 2017 ... Outlook to 2017 Summary ... to 2017" provides key market data on the Europe ...
... announces that a new market research report is ... Asia-Pacific Nephrology and Urology Devices Market Outlook to ... Asia-Pacific Nephrology and Urology Devices Market ... GlobalData,s new report, "Asia-Pacific Nephrology and ...
Cached Medicine Technology:Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 2Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 4Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 5Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 6Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 7Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 8Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 9Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 10Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 11Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 12Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 13Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 14Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 15Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 16Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 17Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 2Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 3Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 4Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 5Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 6Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 7Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 8Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 9Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 10Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 11Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 12Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017 13
The Clinac C family of accelerators are reliable, easy-to-use, flexible and cost-effective systems....
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
Medicine Products: